These innovative treatments , including Semaglutide , belong to a group of drugs called GLP-1 receptor agonists . Primarily developed for treating type 2 diabetes , they operate by helping the body to release sufficient insulin and curbing increased glucose levels. Beyond diabetes, their ability to support slimming has led to substantial interes… Read More